Difesa Capital Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Difesa Capital Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-765,589	Closed	-$14.2K	–	64
2023 Q1	$14.2K	Buy	765,589 +339,889	+80%	+$8.09K	0.01%	120
2022 Q4	$8.09K	Hold	425,700	–	–	0.01%	144
2022 Q3	$93K	Hold	425,700	–	–	0.05%	109
2022 Q2	$138K	Hold	425,700	–	–	0.08%	107
2022 Q1	$294K	Buy	425,700 +25,700	+6%	+$17.8K	0.15%	109
2021 Q4	$392K	Buy	+400,000	New	+$787K	0.27%	91

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

Difesa Capital Management's WGSWW Position: Q2 2023 in Review

Difesa Capital Management sold out of GeneDx Holdings Warrant (WGSWW) in Q2 2023, closing a stake of 765,589 shares — an estimated $14.2K sold.

Difesa Capital Management first reported a position in WGSWW in Q4 2021 and held it in 6 quarters. The position peaked at $392K in Q4 2021. 20 funds tracked by Wall St. Rank hold WGSWW as of Q2 2023.

Difesa Capital Management reported no remaining GeneDx Holdings Warrant position as of Q2 2023 after selling out during the quarter.
Difesa Capital Management sold 765,589 GeneDx Holdings Warrant shares in Q2 2023, an estimated $14.2K.
Difesa Capital Management first reported a position in GeneDx Holdings Warrant in Q4 2021 and held it in 6 quarters.
Difesa Capital Management's GeneDx Holdings Warrant position peaked at $392K in Q4 2021.
20 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q2 2023.

Based on Difesa Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.